Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 5

See more details

Posted by 2 X users
Referenced in 1 clinical guideline sources
11 readers on Mendeley
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109451

Metabolic Studies in an Unusual Case of Asymptomatic Familial Hypobetalipoproteinemia with Hypoalphalipoproteinemia and Fasting Chylomicronemia

Daniel Steinberg, Scott M. Grundy, Henry Y. I. Mok, John D. Turner, David B. Weinstein, W. Virgil Brown, and John J. Albers

Division of Metabolic Disease, Department of Medicine, University of California San Diego, La Jolla, California 92093

Veteran's Administration Hospital, San Diego, California 92191

Northwest Lipid Research Clinic, University of Washington, Seattle, Washington 98104

Find articles by Steinberg, D. in: PubMed | Google Scholar

Division of Metabolic Disease, Department of Medicine, University of California San Diego, La Jolla, California 92093

Veteran's Administration Hospital, San Diego, California 92191

Northwest Lipid Research Clinic, University of Washington, Seattle, Washington 98104

Find articles by Grundy, S. in: PubMed | Google Scholar

Division of Metabolic Disease, Department of Medicine, University of California San Diego, La Jolla, California 92093

Veteran's Administration Hospital, San Diego, California 92191

Northwest Lipid Research Clinic, University of Washington, Seattle, Washington 98104

Find articles by Mok, H. in: PubMed | Google Scholar

Division of Metabolic Disease, Department of Medicine, University of California San Diego, La Jolla, California 92093

Veteran's Administration Hospital, San Diego, California 92191

Northwest Lipid Research Clinic, University of Washington, Seattle, Washington 98104

Find articles by Turner, J. in: PubMed | Google Scholar

Division of Metabolic Disease, Department of Medicine, University of California San Diego, La Jolla, California 92093

Veteran's Administration Hospital, San Diego, California 92191

Northwest Lipid Research Clinic, University of Washington, Seattle, Washington 98104

Find articles by Weinstein, D. in: PubMed | Google Scholar

Division of Metabolic Disease, Department of Medicine, University of California San Diego, La Jolla, California 92093

Veteran's Administration Hospital, San Diego, California 92191

Northwest Lipid Research Clinic, University of Washington, Seattle, Washington 98104

Find articles by Brown, W. in: PubMed | Google Scholar

Division of Metabolic Disease, Department of Medicine, University of California San Diego, La Jolla, California 92093

Veteran's Administration Hospital, San Diego, California 92191

Northwest Lipid Research Clinic, University of Washington, Seattle, Washington 98104

Find articles by Albers, J. in: PubMed | Google Scholar

Published July 1, 1979 - More info

Published in Volume 64, Issue 1 on July 1, 1979
J Clin Invest. 1979;64(1):292–301. https://doi.org/10.1172/JCI109451.
© 1979 The American Society for Clinical Investigation
Published July 1, 1979 - Version history
View PDF
Abstract

A new kindred with asymptomatic hypobetalipoproteinemia is reported. The proband, age 67, differs from previously described cases in several respects: (a) unusually low levels of low density lipoprotein (LDL) cholesterol (4-8 mg/dl); (b) normal triglyceride levels; (c) low levels of high density lipoprotein; (d) mild fat malabsorption; and (e) a defect in chylomicron clearance. On a high-carbohydrate diet his plasma triglyceride levels, instead of rising, actually fell. Turnover of triglycerides in very low density lipoproteins (VLDL) was low (2.8 mg/kg per h). Fractional catabolic rate of LDL protein was just above the normal range (0.655/d) but net turnover was <10% of normal (0.65 mg/kg per d). The half-life of his chylomicrons was 29 min, five times the normal value. Postheparin lipoprotein lipase activity was normal and apolipoprotein C-II, the activator protein for lipoprotein lipase, was present and functional. Apolipoprotein C-III1, however, was not detected in the VLDL fraction, a finding previously reported in patients with abetalipoproteinemia. Fecal excretion of cholesterol was almost twice normal; total sterol balance was increased by ≅40%. The unusual features in the proband that distinguish him from previously described cases and from his affected first-degree relatives suggested that, in addition to the basic gene defect affecting LDL metabolism, he might have a second abnormality affecting clearance of chylomicrons and VLDL. The ratio of apolipoprotein E3 to E2 in his VLDL fraction was 0.93, just below the lower limit of normal, suggesting heterozygosity for E3 deficiency. Whether or not this contributes to his hypertriglyceridemia remains to be established.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 292
page 292
icon of scanned page 293
page 293
icon of scanned page 294
page 294
icon of scanned page 295
page 295
icon of scanned page 296
page 296
icon of scanned page 297
page 297
icon of scanned page 298
page 298
icon of scanned page 299
page 299
icon of scanned page 300
page 300
icon of scanned page 301
page 301
Version history
  • Version 1 (July 1, 1979): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 5
  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
Referenced in 1 clinical guideline sources
11 readers on Mendeley
See more details